Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Atossa Genetics Inc (ATOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Atossa Genetics Inc 107 SPRING STREET SEATTLE WA 98104 USA

P: 206-325-6086 F: 206-430-1288

Description:

Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.

Key Statistics

Overview:

Market Capitalization, $K 24,845
Shares Outstanding, K 5,647
Annual Sales, $ 0 K
Annual Net Income, $ -8,120 K
60-Month Beta 3.59
% of Insider Shareholders 3.10%
% of Institutional Shareholders 13.87%
Float, K 5,472
% Float 96.90%

Growth:

1-Year Return -34.72%
3-Year Return -92.81%
5-Year Return -98.59%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/19/19
Earnings Per Share ttm -4.25
EPS Growth vs. Prev Qtr 77.93%
EPS Growth vs. Prev Year 68.64%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-12 on 04/20/18

ATOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -0.38
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -167.87
Return-on-Assets (Before Tax) -101.07
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.52
Book Value/Share 1.87
Interest Coverage N/A
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar